2ST-24601-38546
3 vaccinations
2 coded responses
30 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 750 / TX
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- JS7-15632-23197
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-21
Registered in v-safe
-
2022-07-12
Dose 1 — Pfizer-BioNTech
- 2022-07-12
- 2022-07-14
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-26
- 2022-08-02
- 2022-08-09
- 2022-08-16
- 2022-08-25
-
2022-09-06
Dose 2 — Pfizer-BioNTech
- 2022-09-13
- 2022-09-20
-
2022-09-27
Survey response — day 21, dose 2, under 3MedDRA: Pyrexia, Rash, Rash erythematous — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever and red bumps all over skin (possible reaction to the MMR vaccine from 9/14/2022)MedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — day 21, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-09-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-04
- 2022-10-11
- 2022-10-18
-
2022-11-01
Dose 3 — Pfizer-BioNTech
-
2022-11-04
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Fever · Rash, not including the immediate area around the injection siteUnder 3 check-in
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-10
- 2022-11-15
- 2022-11-24
- 2022-11-29
- 2022-12-08
- 2022-12-15
-
2023-01-31
Survey response — 3 months, dose 3, under 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-12 | Pfizer-BioNTech | No |
| 2 | 2022-09-06 | Pfizer-BioNTech | No |
| 3 | 2022-11-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Fever and red bumps all over skin (possible reaction to the MMR vaccine from 9/14/2022)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash erythematous | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release